Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).
暂无分享，去创建一个
D. Gladman | M. Weisman | D. Furst | E. Keystone | G. Burmester | S. Wassenberg | B. Kirkham | A. Kavanaugh | D. Wallace | U. Schneider | J. Smolen | J. Kalden | C. Antoni | Z. Tutuncu | J. Molitor | B. Manger | R. Weier